XPeng Inc. Sponsored ADR (XPEV) Stock Slides as Market Rises: Facts to Know Before You Trade

XPeng Inc. (XPEV) shares recently fell 6.15% to $22.42, underperforming the broader market despite a 4.28% gain over the past month. The company is anticipated to report earnings on November 17, 2025, with consensus estimates projecting substantial growth, including quarterly revenue of $2.87 billion (up 99.47% year-over-year) and annual revenue of $11.17 billion (up 96.98% year-over-year), alongside a 73.81% improvement in annual EPS to -$0.22. Analyst sentiment remains positive, with a 20.18% rise in the Zacks Consensus EPS estimate over the last month, earning XPEV a Zacks Rank of #2 (Buy), despite its industry ranking in the bottom 26%.

Analysis

XPeng Inc. (XPEV) experienced a notable daily decline of 6.15% to $22.42, underperforming the S&P 500's 0.13% gain, despite having appreciated 4.28% over the past month. This recent dip contrasts with the broader Auto-Tires-Trucks sector, which saw a 2.25% loss in the same monthly period, indicating specific pressures on XPEV.

Despite recent stock volatility, XPEV's financial outlook appears robust ahead of its November 17, 2025 earnings release. Consensus estimates project substantial year-over-year revenue growth of 99.47% to $2.87 billion for the quarter, and an annual revenue increase of 96.98% to $11.17 billion. Annual EPS is also anticipated to improve significantly by 73.81% to -$0.22, signaling progress towards profitability.

Analyst sentiment remains positive, evidenced by a 20.18% rise in the Zacks Consensus EPS estimate over the last month, culminating in a Zacks Rank of #2 (Buy) for XPEV. This strong company-specific rating exists despite the Automotive - Foreign industry's low Zacks Industry Rank of 185, placing it in the bottom 26% of all industries, which historically underperforms the top half by a 2:1 ratio.

Key Decisions for Investors

• Investors should closely monitor XPEV's upcoming earnings release on November 17, 2025, to validate the projected 99.47% quarterly revenue growth and 73.81% annual EPS improvement.
• Despite XPEV's strong Zacks Rank #2 (Buy), investors should acknowledge the significant headwinds from its industry's low Zacks Industry Rank (bottom 26%), which historically underperforms.
• Given the recent stock slide against a backdrop of strong growth forecasts and positive analyst revisions, investors should assess if current valuation reflects short-term volatility or long-term growth potential.